BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Loke XY, Imran SAM, Tye GJ, Wan Kamarul Zaman WS, Nordin F. Immunomodulation and Regenerative Capacity of MSCs for Long-COVID. Int J Mol Sci 2021;22:12421. [PMID: 34830303 DOI: 10.3390/ijms222212421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Rossello-Gelabert M, Gonzalez-Pujana A, Igartua M, Santos-Vizcaino E, Hernandez RM. Clinical progress in MSC-based therapies for the management of severe COVID-19. Cytokine Growth Factor Rev 2022:S1359-6101(22)00050-8. [PMID: 35843774 DOI: 10.1016/j.cytogfr.2022.07.002] [Reference Citation Analysis]
2 Zoulikha M, Huang F, Wu Z, He W. COVID-19 inflammation and implications in drug delivery. J Control Release 2022;346:260-74. [PMID: 35469984 DOI: 10.1016/j.jconrel.2022.04.027] [Reference Citation Analysis]
3 Hardin LT, Xiao N. Stem Cells: A Promising Therapeutic Target for COVID-19. SCD 2022;12:1-27. [DOI: 10.4236/scd.2022.121001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]